BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Holistic medicine
,
Rapamycin
,
rs2230926
,
DRD2
,
G-protein-coupled receptor binding
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
anti dyskinesia agents
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
EGR1
FOS
GRIN3A
DRD2
COMT
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
response to organic substance
cell periphery
cell differentiation
regulation of nitrogen compound metabolic process
PILON_KLF1_TARGETS_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Haloperidol response across genetic backgrounds
Frontal cortex and corpus striatum of CD-1 mice treated with quetiapine or haloperidol
Striata treated with psychotropic drugs - Timecourse
Drd2 and Drd1a spiny projection neurons parkinsonian treated with high and low dose DOPA
Dopamine Signaling in Parkinson disease model
Explore Curated Studies Results
Literature
Most Relevant Literature
Movement Disorders in Chronic Kidney Disease - A Descriptive Review.
Haloperidol discontinuation in a herpes simplex encephalitis patient with atypical abnormal movement…
PPARĪ³ receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dys…
Synergistic Effects of Efflux Pump Modulators on the Azole Antifungal Susceptibility of Microsporum …
Transient Improvement after Switch to Low Doses of RimabotulinumtoxinB in Patients Resistant to Abob…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa…
Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia
Famotidine for Levodopa-induced Dyskinesia in PD
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Validation of Dyskinesia Rating Scales
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ